litlas
Log inCreate account

G. Caleb Alexander

Active 1998–2026

Also published as
G Caleb Alexander · G Caleb-Alexander
162
Papers
20,277
Citations
78
h-index
152
i10-index

Citations

Citations per year for G. Caleb Alexander1968: 1 citations1999: 2 citations2000: 8 citations2001: 3 citations2002: 5 citations2003: 13 citations2004: 11 citations2005: 20 citations2006: 17 citations2007: 23 citations2008: 27 citations2009: 37 citations2010: 50 citations2011: 49 citations2012: 86 citations2013: 75 citations2014: 77 citations2015: 91 citations2016: 127 citations2017: 180 citations2018: 175 citations2019: 733 citations2020: 755 citations2021: 822 citations2022: 746 citations2023: 431 citations2024: 748 citations2025: 272 citations2026: 13 citations1969–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,270 citing papers, 41.8% of this breakdownUnited Kingdom: 521 citing papers, 6.7% of this breakdownCanada: 493 citing papers, 6.3% of this breakdownChina: 308 citing papers, 3.9% of this breakdownAustralia: 281 citing papers, 3.6% of this breakdownItaly: 231 citing papers, 3% of this breakdownGermany: 208 citing papers, 2.7% of this breakdownNetherlands: 187 citing papers, 2.4% of this breakdownSpain: 136 citing papers, 1.7% of this breakdownSweden: 131 citing papers, 1.7% of this breakdownFrance: 128 citing papers, 1.6% of this breakdownJapan: 118 citing papers, 1.5% of this breakdown
0%41.8%Other 23.1%

Institutions

Fields

  • Medicine78.2%
  • Health Professions3.3%
  • Economics, Econometrics and Finance2.9%
  • Pharmacology, Toxicology and Pharmaceutics2.6%
  • Biochemistry, Genetics and Molecular Biology2.6%
  • Psychology2.4%
  • Other8%

Topics

  • Opioid Use Disorder Treatment7.5%
  • Substance Abuse Treatment and Outcomes3%
  • Pharmaceutical Practices and Patient Outcomes2.8%
  • Pain Management and Opioid Use2.7%
  • HIV, Drug Use, Sexual Risk2.5%
  • Atrial Fibrillation Management and Outcomes2.3%
  • Other79.2%

Coauthors

All papers

Open in search
  1. National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020

    Authors: Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha - Journal of the American Heart Association 2022 cited by 158

  2. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes

    Authors: Justin Reese, Hannah Blau, Elena Casiraghi, Timothy Bergquist, Johanna Loomba, Tiffany J. Callahan, Bryan Laraway, Corneliu Antonescu, Ben Coleman, Michael Gargano, Kenneth J. Wilkins, Luca Cappelletti, Tommaso Fontana, Nariman Ammar, Blessy Antony, T. M. Murali, J. Harry Caufield, Guy Karlebach, Julie A. McMurry, Andrew E. Williams, Richard A. Moffitt, Jineta Banerjee, Anthony Solomonides, Hannah Davis, Kristin Kostka, Giorgio Valentini, David Sahner, Christopher G. Chute, Charisse Madlock‐Brown, Melissa Haendel, Peter N. Robinson, Heidi Spratt, Shyam Visweswaran, Joseph E Flack, Yun Jae Yoo, Davera Gabriel, G. Caleb Alexander, Hemalkumar B. Mehta, Feifan Liu, Robert Miller, Rachel Wong, Elaine Hill, Lorna E. Thorpe, Jasmin Divers - EBioMedicine 2022 cited by 177

  3. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011

    Authors: Dima M. Qato, Jocelyn Wilder, L. Philip Schumm, Victoria Gillet, G. Caleb Alexander - JAMA Internal Medicine 2016 cited by 656

  4. Evaluation of Aducanumab for Alzheimer Disease

    Authors: G. Caleb Alexander, Scott S. Emerson, Aaron S. Kesselheim - JAMA 2021 cited by 234

  5. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016

    Authors: Thomas J. Moore, Hanzhe Zhang, Gerard F. Anderson, G. Caleb Alexander - JAMA Internal Medicine 2018 cited by 355

  6. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

    Authors: Andrew Kolodny, David T. Courtwright, Catherine S. Hwang, Peter Kreiner, John L. Eadie, Thomas W. Clark, G. Caleb Alexander - Annual Review of Public Health 2015 cited by 1,401

  7. Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

    Authors: G. Caleb Alexander, Matthew Tajanlangit, James Heyward, Omar Mansour, Dima M. Qato, Randall S. Stafford - JAMA Network Open 2020 cited by 490

  8. The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms

    Authors: Christopher M. Jones, Faraah Bekheet, Ju Nyeong Park, G. Caleb Alexander - Epidemiologic Reviews 2020 cited by 190

  9. Prescription Opioid Analgesics Commonly Unused After Surgery

    Authors: Mark C. Bicket, Jane J. Long, Peter J. Pronovost, G. Caleb Alexander, Christopher L. Wu - JAMA Surgery 2017 cited by 870

  10. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate

    Authors: Yao Qiao, Jung‐Im Shin, Teresa K. Chen, Lesley A. Inker, Josef Coresh, G. Caleb Alexander, John W. Jackson, Alex R. Chang, Morgan E. Grams - JAMA Internal Medicine 2020 cited by 204

  11. Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

    Authors: Thomas J. Moore, James Heyward, Gerard F. Anderson, G. Caleb Alexander - BMJ Open 2020 cited by 112

  12. Revisiting FDA Approval of Aducanumab

    Authors: G. Caleb Alexander, David S. Knopman, Scott S. Emerson, Bruce Ovbiagele, Richard J. Kryscio, Joel S. Perlmutter, Aaron S. Kesselheim - New England Journal of Medicine 2021 cited by 164

  13. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease

    Authors: Hai V. Nguyen, Shweta Mital, David S. Knopman, G. Caleb Alexander - Neurology 2024 cited by 73

  14. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis

    Authors: Ayobami Akenroye, Grace Lassiter, John W. Jackson, Corinne Keet, Jodi B Segal, G. Caleb Alexander, Hwanhee Hong - Journal of Allergy and Clinical Immunology 2022 cited by 70

  15. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation

    Authors: Ayobami Akenroye, Jodi B Segal, Guohai Zhou, Dinah Foer, Lily Li, G. Caleb Alexander, Corinne Keet, John W. Jackson - Journal of Allergy and Clinical Immunology 2023 cited by 56

  16. Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

    Authors: Dima M. Qato, G. Caleb Alexander, Rena M. Conti, Michael Johnson, L. Philip Schumm, Stacy Tessler Lindau - JAMA 2008 cited by 1,005

  17. Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007–15

    Authors: Jenny S. Guadamuz, Jocelyn Wilder, Morgane C. Mouslim, Shannon N. Zenk, G. Caleb Alexander, Dima M. Qato - Health Affairs 2021 cited by 123

  18. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis

    Authors: Irene B. Murimi, Dora H. Lin, Henk Nab, Hong Kan, Oluwadamilola Onasanya, Jonothan C. Tierce, Xia Wang, Barnabas Desta, G. Caleb Alexander, Edward R. Hammond - BMJ Open 2020 cited by 104

  19. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis

    Authors: Tanawin Nopsopon, Grace Lassiter, Ming‐Li Chen, G. Caleb Alexander, Corinne Keet, Hwanhee Hong, Ayobami Akenroye - Journal of Allergy and Clinical Immunology 2022 cited by 70

  20. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

    Authors: Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William H. Crown, Víctor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy - Journal of the American Heart Association 2016 cited by 451

  21. Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals

    Authors: Ayobami Akenroye, James Heyward, Corinne Keet, G. Caleb Alexander - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 66

  22. The availability of pharmacies in the United States: 2007–2015

    Authors: Dima M. Qato, Shannon N. Zenk, Jocelyn Wilder, Rachel Harrington, Darrell J. Gaskin, G. Caleb Alexander - PLoS ONE 2017 cited by 186

  23. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

    Authors: Xueying Yang, Jing Sun, Rena C. Patel, Jiajia Zhang, Siyuan Guo, Qulu Zheng, Amy L. Olex, Bankole Olatosi, Sharon Weissman, Jessica Y. Islam, Christopher G. Chute, Melissa Haendel, Gregory D. Kirk, Xiaoming Li, Richard A. Moffitt, Hana Akelsrod, Keith A. Crandall, Nora Francheschini, Evan French, Teresa Po‐Yu Chiang, G Caleb-Alexander, Kathleen M. Andersen, Amanda J. Vinson, Todd T. Brown, Roslyn B. Mannon - The Lancet HIV 2021 cited by 165

  24. Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis

    Authors: James Heyward, Omar Mansour, Lily Olson, Sonal Singh, G. Caleb Alexander - PLoS ONE 2020 cited by 107